Top Premarket Gainers-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Top Premarket Gainers

Sep 11, 2024 1:07 AM

07:39 AM EDT, 09/10/2024 (MT Newswires) -- SMX (SMX) shares more than doubled pre-bell Tuesday following a 4.5% gain in the previous session.

Silexion Therapeutics ( SLXN ) shares climbed 35%, extending Monday's rally.

Mission Produce ( AVO ) shares rose 20% after the company reported higher fiscal Q3 adjusted earnings and sales.

Biovie ( BIVI ) shares were up 11% after Monday's 2% gain.

Price: 4.6600, Change: +2.43, Percent Change: +108.97

Previous page： Hi-View Resources Names Robert Horsley as Chief Executive Next page： Regeneron Pharmaceuticals Q4 Adjusted Earnings, Revenue Rise -- Shares Up Pre-Bell

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Hi-View Resources Names Robert Horsley as Chief Executive

Feb 4, 2025

06:48 AM EST, 02/04/2025 (MT Newswires) -- Hi-View Resources ( HVWRF ) on Tuesday appointed Robert Horsley as chief executive. Horsley has served as a director and a consultant to several public and private companies and has experience in different industries including mineral exploration, telecom, CPG, Esports, and technology, the company said. Howard Milne, the out-going CEO, will remain as...

Regeneron Pharmaceuticals Q4 Adjusted Earnings, Revenue Rise -- Shares Up Pre-Bell

Feb 4, 2025

06:46 AM EST, 02/04/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q4 adjusted earnings Tuesday of $12.07 per diluted share, up from $11.86 a year earlier. Analysts polled by FactSet expected $11.35. Revenue for the quarter ended Dec. 31 was $3.79 billion compared with $3.43 billion a year earlier. Analysts surveyed by FactSet expected $3.74 billion. Shares were...

Marathon Petroleum beats fourth quarter profit estimates on midstream strength

Feb 4, 2025

Feb 4 (Reuters) - Top U.S. refiner Marathon Petroleum ( MPC ) beat fourth-quarter profit estimates on Tuesday, as strength in its midstream and renewable diesel segment helped offset a slump in refining margins. The refiner's midstream segment reported an adjusted core profit of $1.71 billion in the quarter, compared with $1.57 billion a year earlier, benefiting from accretive contributions...

Merck's Q4 non-GAAP Earnings, Sales Rise; Provides Full-Year Guidance

Feb 4, 2025

06:47 AM EST, 02/04/2025 (MT Newswires) -- Merck ( MRK ) reported Q4 non-GAAP earnings Tuesday of $1.72 per share, up from $0.03 a year earlier. Analysts polled by FactSet expected $1.61. Sales for the quarter ended Dec. 31 were $15.62 billion, up from $14.63 billion a year earlier. Analysts surveyed by FactSet expected $15.48 billion. For the full year...